224 related articles for article (PubMed ID: 18328640)
1. Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice.
Bisaga A; Kos T; Wójcikowski J; Daniel WA; Popik P
Drug Alcohol Depend; 2008 May; 95(1-2):147-51. PubMed ID: 18328640
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
3. Modulation of src-kinase attenuates naloxone-precipitated opioid withdrawal syndrome in mice.
Rehni AK; Singh N
Behav Pharmacol; 2011 Apr; 22(2):182-90. PubMed ID: 21285874
[TBL] [Abstract][Full Text] [Related]
4. Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice.
Pałucha-Poniewiera A; Novák K; Pilc A
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1454-7. PubMed ID: 19660510
[TBL] [Abstract][Full Text] [Related]
5. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice.
Papaleo F; Contarino A
Behav Brain Res; 2006 Jun; 170(1):110-8. PubMed ID: 16580078
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
Tseng LF; Brase DA; Loh HH
Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of the physical dependence on proline analog of dermorphin and morphine].
Guzevatykh LS; Valuĭskikh DV; Voronina TA; Emel'ianova TG; Andreeva LA; Alfeeva LIu; Miasoedov NF
Eksp Klin Farmakol; 2005; 68(3):16-9. PubMed ID: 16047673
[TBL] [Abstract][Full Text] [Related]
8. Baclofen reestablishes micro-opioid receptor levels modified by morphine withdrawal syndrome in either sex.
Diaz SL; Kemmling AK; Bonavita CD; Rubio MC; Balerio GN
Synapse; 2004 Oct; 54(1):24-9. PubMed ID: 15300881
[TBL] [Abstract][Full Text] [Related]
9. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
Hodgson SR; Hofford RS; Norris CJ; Eitan S
Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
[TBL] [Abstract][Full Text] [Related]
10. Opiate physical dependence and N-methyl-D-aspartate receptors.
Noda Y; Nabeshima T
Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
[TBL] [Abstract][Full Text] [Related]
11. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
Farzin D
Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
[TBL] [Abstract][Full Text] [Related]
12. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
13. Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?
Taraschenko OD; Panchal V; Maisonneuve IM; Glick SD
Eur J Pharmacol; 2005 Apr; 513(3):207-18. PubMed ID: 15862802
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis.
Pechnick RN; Poland RE
J Pharmacol Exp Ther; 2004 May; 309(2):515-22. PubMed ID: 14742749
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
Trang T; Koblic P; Kawaja M; Jhamandas K
Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
[TBL] [Abstract][Full Text] [Related]
16. Further studies on the enhanced affinity of opioid receptors for naloxone in morphine-dependent mice.
Kitano T; Takemori AE
J Pharmacol Exp Ther; 1979 Jun; 209(3):456-61. PubMed ID: 220409
[No Abstract] [Full Text] [Related]
17. Interferon as an endocoids candidate preventing and attenuating opiate addiction.
Dafny N
Prog Clin Biol Res; 1985; 192():269-76. PubMed ID: 4080713
[TBL] [Abstract][Full Text] [Related]
18. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
19. Decrease of morphine-induced reward effects and withdrawal symptoms in mice overexpressing gamma-aminobutyric acid transporter I.
Hu JH; Yang N; Ma YH; Zhou XG; Zhang XY; Jiang J; Mei ZT; Fei J; Guo LH
J Neurosci Res; 2003 Nov; 74(4):614-21. PubMed ID: 14598306
[TBL] [Abstract][Full Text] [Related]
20. Aquaporin 4 deficiency modulates morphine pharmacological actions.
Wu N; Lu XQ; Yan HT; Su RB; Wang JF; Liu Y; Hu G; Li J
Neurosci Lett; 2008 Dec; 448(2):221-5. PubMed ID: 18973795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
